Travel Medicine and Infectious Disease
Volume 7, Issue 6 , Pages 337-343 , November 2009

Outcomes of diarrhea management in operations Iraqi Freedom and Enduring Freedom

  • Jamey A. Brown

      Affiliations

    • Womack Army Medical Center, Fort Bragg, NC, USA
    • ,
  • Mark S. Riddle

      Affiliations

    • Naval Medical Research Center, Enteric Diseases Department, Silver Spring, 503 Robert Grant Ave., MD 20910, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 301 319 7686; fax: +1 301 319 7673.
    • ,
  • Shannon D. Putnam

      Affiliations

    • U.S. Naval Medical Research Unit No. 2, Jakarta, Indonesia
    • ,
  • Carey D. Schlett

      Affiliations

    • U.S. Naval Medical Research Unit No.3, Cairo, Egypt
    • ,
  • Adam W. Armstrong

      Affiliations

    • U.S. Naval Medical Research Unit No.3, Cairo, Egypt
    • ,
  • James J. Jones

      Affiliations

    • Army Central Command, Troop Medical Clinic, Doha, Qatar
    • ,
  • David R. Tribble

      Affiliations

    • Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    • ,
  • John W. Sanders

      Affiliations

    • Naval Medical Research Center Detachment, Lima, Peru

Received 27 February 2009 ,Revised 25 August 2009 ,Accepted 2 September 2009.

References 

  1. Sanders JW, Putnam SD, Riddle MS, Tribble DR. Military importance of diarrhea: lessons from the Middle East. Curr Opin Gastroenterol. 2005;21:9–14
  2. Sanders JW, Putnam SD, Frankart C, Frenck RW, Monteville MR, Riddle MS, et al. Impact of illness and non-combat injury during operations Iraqi Freedom and Enduring Freedom (Afghanistan). Am J Trop Med Hyg. 2005;73(4):713–719
  3. Hyams KC, Bourgeois AL, Merrell BR, Rozmajzl P, Escamilla J, Thornton SA, et al. Diarrheal disease during operation desert shield. N Engl J Med. 1991;325:1423–1428
  4. Putnam SD, Sanders JW, Frenck RW, Monteville M, Riddle MS, Rockabrand DM, et al. Self-reported description of diarrhea among military populations in operations Iraqi Freedom and Enduring Freedom. J Travel Med. 2006;13:92–99
  5. Hill DR, Ericsson CD, Pearson RD, Keystone JS, Freedman DO, Kozarsky PE, et al. Infectious Diseases Society of America The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006 Dec 15;43(12):1499–1539
  6. Ericsson CD. Traveler's diarrhea: epidemiology, prevention, and self-treatment. Infect Dis Clin North Am. 1998;12:285–303
  7. Ericsson CD, DuPont HL, Mathewson JJ. Single dose of loxacin plus loperamide compared with single dose or three days of ofloxacin in the treatment of traveler's diarrhea. J Travel Med. 1997;4:3–7
  8. Sanders JW, Putnam SD, Riddle MS, Tribble DR, Jobanputra NK, Jones JJ, et al. The epidemiology of self-reported diarrhea in operations Iraqi Freedom and Enduring Freedom. Diagn Microbiol Infect Dis. 2004;50:89–93
  9. Cusick J. A wilcoxon-type test for trend. Stat Med. 1985;4(1):87–90
  10. Long JS, Freese J. Regression models for categorical dependent variables using Stata. Rev. ed.. College Station, TX: Stata Press; 2003;
  11. Ryan ET, Kain KC. Health advice and immunizations for travelers. N Engl J Med. 2000;342:1716–1725
  12. Riddle MS, Tribble DR, Jobanputra NK, Jones JJ, Putnam SD, Frenck RW, et al. Knowledge, attitudes, and practices regarding epidemiology and management of travelers' diarrhea: a survey of front-line providers in Iraq and Afghanistan. Mil Med. 2005;170:492–495
  13. DuPont HL, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med. 1993;328:1821–1827
  14. DuPont HL, Sullivan P, Pickering LK, Haynes G, Ackerman PB. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican University. Gastroenterology. 1977;73:715–718
  15. Steinhoff MC, Douglas RG, Greenberg HB, Callahan DR. Bismuth subsalicylate therapy of viral gastroenteritis. Gastroenterology. 1980;78:1495–1499
  16. Gorbach SL. Bismuth therapy in gastrointestinal diseases. Gastroenterology. 1990;99:863–875
  17. Johnson PC, Ericsson CD, DuPont HL, Morgan DR, Bitsura JA, Wood LV. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea. JAMA. 1986;255:757–760
  18. DuPont HL. Treatment of travelers' diarrhea. J Travel Med. 2001;8(Suppl. 2):S31–S33
  19. Caeiro JP, DuPont HL, Albrecht H, Ericsson CD. Oral rehydration therapy plus loperamide versus loperamide alone in the treatment of traveler's diarrhea. Clin Infect Dis. 1999;28:1286–1289
  20. Ericsson CD, Johnson PC, Dupont HL, Morgan DR, Bitsura JA, de la Cabada FJ. Ciprofloxacin or Trimethoprim–Sulfamethoxazole as initial therapy for travelers' diarrhea: a placebo-controlled, randomized trial. Ann Intern Med. 1987;106:216–220
  21. Steffen R, Jori J, DuPont HL, Mathewson JJ, Stürchler D. Treatment of travelers' diarrhea with fleroxacin: a case study. J Antimicrob Chemother. 1993;31:767–776
  22. Mattila L, Peltola H, Siitonen A, Kyrönseppä H, Simula I, Kataja M. Short-term treatment of travelers' diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis. 1993;17:779–782
  23. Ericsson CD, Nicholls-Vasquez I, DuPont HL, Mathewson JJ. Optimal dosing of trimethoprim/sulfamethoxazole when used with loperamide to treat travelers' diarrhea. Antimicrob Agents Chemother. 1992;36:2821–2824
  24. Taylor DN, Sanchez JL, Candler W, Thornton S, McQueen C, Echeverria P. Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone: a placebo-controlled, randomized trial. Ann Intern Med. 1991;114:731–734
  25. Ericsson CD, DuPont HL, Mathewson JJ, West MS, Johnson PC, Bitsura JA. Treatment of travelers' diarrhea with sulfamethoxazole and trimethoprim and loperamide. JAMA. 1990;263:257–261

PII: S1477-8939(09)00144-6

doi: 10.1016/j.tmaid.2009.09.001

Travel Medicine and Infectious Disease
Volume 7, Issue 6 , Pages 337-343 , November 2009

Article Tools